Literature DB >> 392560

A review of hypoxic cell radiosensitization in experimental tumors.

J F Fowler, J Denekamp.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 392560     DOI: 10.1016/0163-7258(79)90039-1

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  8 in total

1.  Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations.

Authors:  A Rojas; R J Hodgkiss; M R Stratford; M F Dennis; H Johns
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

2.  Transition from laboratory to clinic in cancer treatment. Abstracts of symposium papers.

Authors: 
Journal:  Br J Cancer       Date:  1981-05       Impact factor: 7.640

3.  Enhancement of hyperthermochemotherapy for human gastric cancer in nude mice by thermosensitization with nitroimidazoles.

Authors:  S Fujimoto; M Ohta; R D Shrestha; M Kokubun; T Miyoshi; T Mori; N Arimizu; K Okui
Journal:  Br J Cancer       Date:  1988-07       Impact factor: 7.640

4.  Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.

Authors:  A Rojas; F A Stewart; J Denekamp
Journal:  Br J Cancer       Date:  1983-01       Impact factor: 7.640

5.  Is tumour radiosensitization by misonidazole a general phenomenon?

Authors:  J Denekamp; D G Hirst; F A Stewart; N H Terry
Journal:  Br J Cancer       Date:  1980-01       Impact factor: 7.640

6.  Interaction of radiosensitizers and WR-2721. I. Modification of skin radioprotection.

Authors:  A Rojas; F A Stewart; J Denekamp
Journal:  Br J Cancer       Date:  1982-05       Impact factor: 7.640

7.  In vivo assessment of basic 2-nitroimidazole radiosensitizers.

Authors:  M V Williams; J Denekamp; A I Minchinton; M R Stratford
Journal:  Br J Cancer       Date:  1982-07       Impact factor: 7.640

8.  Enhancing effect of pre-treatment of cells with misonidazole in hypoxia on their response to melphalan in air.

Authors:  E Smith; I J Stratford; G E Adams
Journal:  Br J Cancer       Date:  1982-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.